Published in Br J Cancer on May 04, 2001
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses. PLoS One (2013) 1.48
Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon (2012) 1.47
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer (2005) 1.18
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. J Viral Hepat (2009) 1.10
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One (2013) 1.10
Estimating the incidence of colorectal cancer in Sub-Saharan Africa: A systematic analysis. J Glob Health (2012) 1.07
Increase in female liver cancer in the Gambia, West Africa: evidence from 19 years of population-based cancer registration (1988-2006). PLoS One (2011) 1.01
Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia. Virol J (2006) 1.00
Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005. Br J Cancer (2009) 0.95
Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection. Environ Health Perspect (2011) 0.91
Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Virol J (2008) 0.88
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus. J Clin Microbiol (2008) 0.85
Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer (2014) 0.83
20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West Africa. PLoS One (2013) 0.81
Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans. Cancer Epidemiol (2010) 0.80
Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal. J R Soc Med (2015) 0.78
The role of cervical mediastinoscopy in Nigerian thoracic surgical practice. Pan Afr Med J (2016) 0.78
An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77
HSV-1/HSV-2 Infection-Related Cancers in Bantu Populations Driving HIV-1 Prevalence in Africa: Tracking the Origin of AIDS at the Onset of the 20th Century. Case Rep Oncol (2016) 0.75
Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014. Front Oncol (2016) 0.75
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet (1996) 3.54
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol (1999) 1.90
Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer (2000) 1.70
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
Parity as a risk factor for cervical cancer. Am J Epidemiol (1989) 1.33
The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis (1990) 1.31
Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995-1997. Cancer (2000) 1.25
Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer (1994) 1.24
Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis (1990) 1.15
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg (1992) 1.15
Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995. Int J Cancer (1997) 1.14
The first 2 years of the Gambian National Cancer Registry. Br J Cancer (1990) 1.14
Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes Control (2000) 1.09
Real-time ultrasonography in detection of primary liver cancer in intertropical Africa. Lancet (1985) 1.07
Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts. Am J Epidemiol (1992) 0.97
Pattern of sexually transmitted diseases among pregnant women in Burkina Faso, west Africa: potential for a clinical management based on simple approaches. Genitourin Med (1997) 0.97
Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ (1990) 10.85
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11
The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet (1991) 6.00
Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ (1991) 5.44
Follow up study of children born to mothers resident in Seascale, West Cumbria (birth cohort). Br Med J (Clin Res Ed) (1987) 5.42
Follow up study of children born elsewhere but attending schools in Seascale, West Cumbria (schools cohort). Br Med J (Clin Res Ed) (1987) 4.38
Measles and atopy in Guinea-Bissau. Lancet (1996) 4.03
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax (2005) 3.81
Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79
Deviation from prescribed drug treatment after discharge from hospital. Br Med J (1976) 3.35
Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ (1984) 3.32
The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol (1994) 3.23
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ (1995) 3.21
Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer (1993) 3.13
Mobility and the spread of human immunodeficiency virus into rural areas of West Africa. Int J Epidemiol (2003) 3.06
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
A novel lymphotropic herpesvirus. Lancet (1987) 2.89
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Methods and basic data of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ (1990) 2.70
Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer (1997) 2.65
Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer (1993) 2.58
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Lancet (1997) 2.50
The emergence of life from iron monosulphide bubbles at a submarine hydrothermal redox and pH front. J Geol Soc London (1997) 2.46
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
Risk factors for transmission of hepatitis B virus to Gambian children. Lancet (1990) 2.35
Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer (2004) 2.30
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS (2000) 2.26
The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer (2002) 2.18
Do bedbugs transmit hepatitis B? Lancet (1994) 2.17
Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question. BMJ (2001) 2.15
Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer (2003) 2.14
Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries. Am J Epidemiol (1999) 2.12
The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12
Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res (2000) 2.09
Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. J Pediatr (1993) 2.08
Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen (2003) 2.07
What level of hepatitis B antibody is protective? J Infect Dis (1999) 2.02
An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. J Epidemiol Community Health (1986) 2.02
Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health (2001) 2.01
Risk factors for mortality from acute lower respiratory tract infections in young Gambian children. Int J Epidemiol (1993) 1.99
Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal. Am J Epidemiol (1997) 1.99
How successful is screening for congenital disease of the hip? Am J Public Health (1981) 1.97
Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ (2002) 1.96
The management of hypertension--a study of records in general practice. J R Coll Gen Pract (1979) 1.95
Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol Biochem Parasitol (1991) 1.92
Effectiveness of neonatal screening for congenital dislocation of the hip. Lancet (1978) 1.92
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis (2006) 1.91
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol (1999) 1.90
Hepatitis B vaccination: protection for how long and against what? BMJ (1993) 1.90
Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull (1996) 1.87
The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect (1999) 1.87
Patterns of cigarette sales and lung cancer mortality in some central and eastern European countries, 1960-1989. Cancer (1995) 1.86
An overview of cancer survival in developing countries. IARC Sci Publ (1998) 1.84
T-lymphocyte subsets in West African children: impact of age, sex, and season. J Pediatr (1997) 1.82
Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet (1996) 1.81
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer (2000) 1.79
International variations in the incidence of neuroblastoma. Int J Cancer (1992) 1.77
Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev (2000) 1.76
Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer (2000) 1.70
Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health (2004) 1.70
Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia. J Pediatr (1999) 1.68
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol (2005) 1.64
Aids and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS (1999) 1.61
International variations in the incidence of childhood renal tumours. Br J Cancer (1990) 1.61
Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health (2000) 1.60
Cancer survival in Kampala, Uganda. Br J Cancer (2005) 1.58
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer (1998) 1.56
Cancer incidence in Karachi, Pakistan: first results from Karachi Cancer Registry. Int J Cancer (2000) 1.55
Sex-specific differences in mortality after high-titre measles immunization in rural Senegal. Bull World Health Organ (1994) 1.54
Genetic regulation of immune responses to vaccines in early life. Genes Immun (2004) 1.54
Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer (2006) 1.54
Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res (1988) 1.54
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol (1999) 1.54
Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J Virol (1990) 1.53
The demonstration and function of antibodies in the gastrointestinal tract. Gut (1972) 1.53
A British Medical Association Lecture on Post-Encephalitic Parkinsonism. Br Med J (1926) 1.52
Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer (1998) 1.52
Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer (2008) 1.52
A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations. Int J Tuberc Lung Dis (1999) 1.51
Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer (1990) 1.47
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet (1991) 1.46
Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J (2005) 1.46
Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. Lancet (2005) 1.46
Cervical cytology screening in two Yorkshire areas: pattern of service. Public Health (1981) 1.45
The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS (1993) 1.45
The clinical spectrum of respiratory syncytial virus disease in The Gambia. Pediatr Infect Dis J (1998) 1.45
A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol (1998) 1.44